SCHEMBL24591605

SCHEMBL24591605

[N-]=[N+]=NC1[C@H](c2csc3c(N)ncnc23)O[C@H](CO)[C@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 3/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HBB P68871 1/20 0.41
▸ ADORA3 P0DMS8 3/20 0.36
▸ GAPDH P04406 3/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ SLC28A1 O00337 1/20 0.36
▸ MAP3K7 O43318 1/20 0.36
▸ SLC28A2 O43868 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ STAT6 P42226 1/20 0.36
▸ PI4KA P42356 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3297374 0.83 HIF1A (0.65) HIF1ASMN1; SMN2ADORA3GAPDHADORA1
SCHEMBL21880798 0.79 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL19644605 0.79 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL17453462 0.79 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL17453477 0.76 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL21880481 0.76 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL17453469 0.76 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL19644632 0.76 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL21137373 0.76 HIF1A (0.34) HIF1AALDH1A1
SCHEMBL17453489 0.75 HIF1A (0.35) HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
Send feedback